Red Net Time News October 15th (Correspondent Li Sixuan) Recently, the key scientific research project of the National Clinical Medical Center for Neurological Diseases "Certificate Double Anti-Correction Action of Cerebrovascular Disease" was officially launched and awarded at Chenzhou Fourth People's Hospital . Director Meng Xia, National Clinical Medical Research Center for Neurological Diseases, Li Qiujie, Academic Manager of the Management Department, Zhou Lei, Head of the Transformation Group of the Project Department, Zhou You, Regional Project Manager, Hospital leaders, heads of relevant business departments, and relevant medical staff of the stroke center attended the launch meeting.
National Clinical Medical Research Center for Neurological Diseases "Application Unit for Accurate Double Antibody in Cerebrovascular Diseases".
"Ceclesy Vascular Disease Precision Double Antibody Action Project" is a major national scientific research project in the 13th Five-Year Plan undertaken by the National Clinical Medical Research Center for Neurological Diseases. It marks the entry of the "precision Double Antibody" era of stroke treatment. The official launch of this project in the hospital is inseparable from the help, guidance and trust of experts from the National Clinical Medical Research Center for Neurological Diseases. As a cooperative unit that was the first to introduce a national clinical application promotion project in the city, it marks that the hospital's diagnosis and treatment in the field of ischemic cerebrovascular disease, recurrence prevention and treatment has entered the stage of precision medicine, which will be conducive to the high-quality development of the hospital's stroke diagnosis and treatment service system, and will also be conducive to promoting the hospital's in-depth optimization of the quality of medical services and the level of disease treatment, improve the secondary prevention and diagnosis and treatment capabilities of stroke, and play a positive role in reducing the risk of recurrence of stroke patients in the hospital and enhancing the welfare of local people. The hospital will take this opportunity to further promote the application of clinical projects, comprehensively improve the level of medical technology, and benefit the majority of patients.
